Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Chinese Journal of Cancer》 1992-03
Add to Favorite Get Latest Update

PHARMACOLOGY. CLINICAL TOXICOLOGY AND DOSE SCHEDULE OF IFOSFAMIED/MESNA

W. P. BRAND, K. HERDRICH et al(Med. Deptm. Oncelogy, AST A Pharma Aktiengesellschaft, Weismullerstr. 45 D- 6000Frankfurt 1)  
Strucfcral difference of IFO to CTX, main route of metabolism and mechanism of renal and central nervous system toxicity were described.
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【References】
Chinese Journal Full-text Database 3 Hits
1 YIAO Ding-quail(Hunan Provincial Tumor Hospital, Changsha 410006, Hunan, China);A Combined Chemotherapy Regimen Composed Mainly of Ifosfamide for the Treatment of Ad- vanced Recurrent Nasopharyngeal Carcinoma[J];Hunan Medical Journal;2002-08
2 YAO Ding-qun, WANG An-lan, ZOU Wen-wei(Department of Clinical Oncology, Hunan Provincial Tumor Hospital, Changsha 410006, Hunan, China);Comparative Study on the Short-term Therapeutic Efficacy of NP and IP Regimens for the Treatment of Recurrent Metastatic Breast Cancer in Its Late Stage[J];Journal of Elinical Research;2004-03
3 Non-Small Cell Lung Cancer PAN Ming,CHEN Ping,ZAO Yu-juan (Department of Medical Oncology Cancer Hospital of Sichuan Provincial,Chengdu 610041 P.R.China);Comparison of Treatmental Results from CAP?EP and IP Regimens for Advanced[J];West China Medical Journal;2001-04
【Co-references】
Chinese Journal Full-text Database 7 Hits
1 GUAN Zhong-zhen ZHAO Ti-ping SUN Yan et al (Tumor Hospital. Sun Yat-sen University of Medical Sciences, Guangzhou 510060)(Cancer Hospital, Shanghai Medical University, Shanghai . 200032) (Cancer Instiute & Hospital, Chinese Academy of Medial Science, Beijing . 100021);PHASE II CLINICAL STUDY OF IFOSFAMIDE IN LYMPHOMAS AND SMALL CELL LUNG CANCER[J];Chinese Journal of Cancer;1992-03
2 (Cancer Institute & Hospital, Chinese Academy of Medical Sciences Beijing , China. 100021);RECENT PROGRESS OFF CLINICAL TRIALS OF IFOSFAMIDE SUN Yan[J];Chinese Journal of Cancer;1992-03
3 K. H. Antmar. et al( Dana-farber institute, Boston, USA);EFOSFAMIDE IN SARCOMAS, ALORE & IN COMBINATION AT STANDARD & HIGH DOSE SCHEDLES[J];Chinese Journal of Cancer;1992-03
4 V.R.PAI D.M.PARIKH A.T.MAZUMDAR R.S.RAO(Division of Medical oncology and Surgery , TATA Memorial Hospital, Parel,India Bombay 400012);PHASE Ⅱ STUDY OF HIGH DOSE IFOSFAMIDE AS A SINGLE AGENT AND IN COMBINATION WITH CISPLATINUM IN THE TREATMENT OF ADVANCED AND/ OR RECURRENT SQUAMOUS CELL CARCINOMA OF HEAD AND NECK[J];Chinese Journal of Cancer;1992-03
5 ZHANG Ai qin*, GUO Gen fa Zhejiang Provincial Cancer Hospital, Hangzhou 310022, P.R.China;Vinorelbine Combined with Cisplatin for Treatment of Patients with Metastatic Breast Carcinoma[J];Chinese Journal of Cancer;2001-12
6 Yong Weiben, et al;A Preliminary Investigation of Bone Marrow Involvement in Malignant Lymphoma[J];Beijing Medical Journal;1981-06
7 Zhang Lingyun , Department of Oncology,Xiangfan Central Hospital,Hubei 441021;Combination chemotheraphy with vinorelbine and doxorubicin intreatment of metastatic breast cancer[J];Chinese Clinical Oncology;2001-04
【Secondary References】
Chinese Journal Full-text Database 1 Hits
1 YIAO Ding-quail(Hunan Provincial Tumor Hospital, Changsha 410006, Hunan, China);A Combined Chemotherapy Regimen Composed Mainly of Ifosfamide for the Treatment of Ad- vanced Recurrent Nasopharyngeal Carcinoma[J];Hunan Medical Journal;2002-08
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved